A Study of LY2484595 on Pharmacokinetics in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions
Healthy Participants
Interventions
DRUG

LY2484595

Administered orally

DRUG

Placebo

Administered orally

DRUG

Ketoconazole

Administered orally

Trial Locations (2)

32117

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Daytona Beach

75247

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Dallas

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01448824 - A Study of LY2484595 on Pharmacokinetics in Healthy Participants | Biotech Hunter | Biotech Hunter